Magruder Hospital Achieves Fourth Consecutive Year of Zero Deficiencies in Annual FDA MQSA Inspection

Magruder Hospital is proud to announce that its mammography services have once again passed the annual U.S. Food & Drug Administration (FDA) Mammography Quality Standards Act (MQSA) inspection with zero deficiencies. This achievement marks the fourth consecutive year the department has received a perfect review.

This outstanding performance underscores the consistent excellence and unwavering commitment of the mammography team—Sarah Kraus, Emily Meyer, and Melanie Smith. Their dedication to meeting and exceeding the FDA MQSA’s rigorous daily requirements ensures the highest quality of patient care and imaging services.

“Our team’s diligence in maintaining quality standards, meeting credentialing requirements, tracking interpretation volumes, completing continuing education, and performing daily monitor QC testing for each radiologist is extraordinary,” said Robin Lemley, MBA, CRA, CNMT, R.T.(N)(ARRT), Senior Director, Ancillary Services. “The workload is substantial, and their precision and professionalism make achievements like this possible.”

The continued success of the mammography program reinforces Magruder’s commitment to delivering exceptional breast imaging services to the community.